ArticleReceptors & clinical investigation2016

EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery.

Xuhui Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.